Chiral compounds play a vital role in the fields of medicine and materials science . Among the many approaches to obtain these compounds, asymmetric catalytic synthesis stands out as one of the most efficient and environmentally friendly methods. The ongoing scientific pursuit of chiral compounds has driven the rapid development of new catalysts for asymmetric reactions.

Figure 1. Wide range of applications of Feng’s chiral nitroxides

 

The Ideal Catalyst—Still a Challenge

In theory, an ideal catalyst should possess the following attributes:

  • Easy structural modification

  • Low cost

  • High stability

  • Operational simplicity

  • Excellent activity and selectivity

However, no single universal chiral catalyst has yet met all these criteria.

Feng Xiaoming’s Contribution to Chiral Catalysis

Professor Feng Xiaoming of Sichuan University is a renowned chemist in the field of chiral organic synthesis. After two decades of dedicated research into highly efficient and selective chiral catalysts and reactions, his team has successfully designed a class of ligands and catalysts known as N,N′-dioxy compounds (dinitroxide compounds) .

These dinitroxide compounds break traditional expectations by replacing rigid ligand skeletons with a structure that combines rigidity and flexibility , much like a nunchaku . This flexibility allows the reaction environment to be precisely controlled, ensuring that chemical components interact in a highly predictable manner.

Furthermore, the nitrogen-based framework can be fine-tuned to direct various reactions. This enables the production of drug molecules in their most effective single enantiomer form , rather than as racemic mixtures, opening new avenues in asymmetric drug synthesis .

In recognition of his groundbreaking contributions, Feng Xiaoming was awarded the 2018 Future Science Award in Material Science for inventing new catalysts and reaction methods that revolutionized the synthesis of organic, especially pharmaceutical, molecules 1–3.



Roskamp-Feng Reaction: A New Asymmetric Strategy

The Roskamp reaction traditionally involves the Lewis acid-catalyzed reaction of α-acetoxy diazoesters with aldehydes , producing β-keto esters . However, due to the reaction’s rearrangement mechanism, it often yields multiple by-products, primarily from hydrogen migration.

Feng Xiaoming’s team improved the process to achieve asymmetric conversion with high yield and minimal by-products . This optimized version is now known as the Roskamp–Feng reaction (Figure 2), highlighting a major advancement in the field of asymmetric synthesis.

Figure 2:Roskamp-Fengreaction, (using Feng's chiral nitroxide L3 (Cat. NO. 1595287) -Sc(OTf)3 Catalyst, the corresponding selectivity is as high as 98%, and the yield can reach 99%)

 

Advantages of Chiral Dinitroxide Series Catalysts

  1. Broad Applicability:
    Demonstrates wide substrate tolerance, applicable to nearly 20 different asymmetric reaction types , including:

    • Asymmetric haloamination of ketenes

    • α-Amination of ketones
      (See Figure 1 and Table 1)

  2. Structural Flexibility:
    A unique balance of rigidity and flexibility allows for high customizability. Substituents can be easily modified to suit specific reaction requirements.

  3. Versatile Catalytic Roles:
    These compounds can function either as:

    • Organic small-molecule catalysts, or

    • Ligands in metal-based complex catalysts (e.g., with scandium, copper, nickel, magnesium, lanthanides, etc.)

  4. Outstanding Stereoselectivity:
    Provide excellent enantioselectivity and diastereoselectivity across a wide range of reaction types.

  5. Commercial Availability:
    J&K Scientific is the exclusive supplier of this series of chiral dinitroxide products. The offerings include:

    • High purity materials

    • Multiple packaging options

    • Reliable inventory availability

 

Table 1. Some examples of applications of dinitroxide-metal complex catalytic asymmetric synthesis


Nitroxide metal complex

Application examples

Cat. No.
(Dinitroxide/metal salt)

L1/Y(OTf) 3

Homologation of α-ketoesters and α-diazoesters 4

1595283
214543

L2/Sc(OTf) 3

1 Roskamp–Feng reaction 5 ;
2 Electrophilic addition of α-diazoesters to ketones 6 ;
3 ring expansion of isatins with α-diazoesters 7 ;
4 Baeyer–Villiger oxidation 8 ;
5 inverse electron-demand aza-Diels–Alder reaction 9 ;
6 reduction reaction 10 ;

1595287
21-2000

L2/Ni(BF4) 2

8 + 2 cycloaddition 11 ;

1595287
93-2841

L3/Mg(ClO4) 2

1,3-dipolar cycloaddition of nitrile imines 12;

1595288
93-1246

L2/L4/In(OTf) 3

Hetero-Diels–Alder reaction 13 ;

1595285
943368

L4/Sc(OTf) 3

1 α-Functionalization of 3-substituted oxindoles 14 ;
2 epoxidation of enones with H2O2 15 ;

1595285
21-2000

L4/Ni(ClO4) 2

Ene reaction 16 ;

1595285
93-2834



Feng's Ligand Piperidine Framework Product List




Product name NO-Feng-PBnPPi, 95%

Product name NO-Feng-PBuPPi, 95%

Product name NO-Feng-PCyPPi, 95%

Cat. No 2699021

Cat. No 2699022

Cat. No 2699023

SKU: 1085279-20-4

SKU: 959152-93-3

SKU: 1017605-60-5

50 mg, 250 mg

50 mg, 250 mg

50 mg, 250 mg

 




Product name NO-Feng-PDEtMPPi, 95%

Product name NO-Feng-PDEtPPi, 95%

Product name NO-Feng-PDMPPi, 95%

Cat. No 2699019

Cat. No 2699018

Cat. No 2699017

SKU: 1502814-74-5

SKU: 1313215-46-1

SKU: 1227411-35-9

50 mg, 250 mg

50 mg, 250 mg

50 mg, 250 mg




Product name NO-Feng-PDiPPPi, 99%

Product name NO-Feng-PPhPPi, 95%

Product name NO-Feng-PTMPPP, 99%

Cat. No 1595285

Cat. No 2699020

Cat. No 1595286

SKU: 1000051-40-0

SKU: 945564-77-2

SKU: 1310585-10-4

50 mg, 250 mg

50 mg, 250 mg

50 mg, 250 mg




Feng's Ligand Proline Backbone Product List




Product name NO-Feng-PBnPPr, 95%

Product name NO-Feng-PDEtMPPr, 95%

Product name NO-Feng-PDEtPPr, 95%

Cat. No 2699014

Cat. No 2699015

Cat. No 2699012

SKU: 870716-86-2

SKU: 1502814-73-4

SKU: 1313215-45-0

50 mg, 250 mg

50 mg, 250 mg

50 mg, 250 mg




Product name NO-Feng-PDiPPPr, 99%

Product name NO-Feng-PDMPPy, 99%

Product name NO-Feng-PDPhMPPr, 95%

Cat. No 1595283

Cat. No 1595284

Cat. No 2699016

SKU: 945564-85-2

SKU: 1330533-36-2

SKU: 870716-88-4

50 mg, 250 mg

50 mg, 250 mg

50 mg, 250 mg


Product name NO-Feng-PPhPPr, 95%

Cat. No 2699013

SKU: 945564-81-8

50 mg, 250 mg




Von's Ligand Ramipril Backbone



Product name NO-Feng-PDiPPRa, 99%

Product name Feng ligand L5: L3-RaEt2, 95%

Cat. No 1595287

Cat. No 9239507

SKU: 1005495-74-8

SKU: /

50 mg, 250 mg

50 mg



    By 向阳 翟

    Share:

    Just added to your wishlist:
    My Wishlist
    You've just added this product to the cart:
    Go to cart page